Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-200
Closed -$56.4K 486
2025
Q3
$56.4K Buy
+200
New +$58K ﹤0.01% 475

Other funds holding AMGN

Avestar Capital's AMGN Position: Q2 2026 in Review

Avestar Capital increased its Amgen (AMGN) stake by 2.1% in Q2 2026, buying an estimated $25.3K and bringing the position to 3,577 shares worth $1.3M. The position accounts for 0.07% of the portfolio, ranked #196.

Avestar Capital first reported a position in AMGN in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.66M in Q1 2025. 1,530 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Avestar Capital held 3,577 shares of Amgen worth $1.3M as of Q2 2026.
  • Avestar Capital bought 74 Amgen shares in Q2 2026, an estimated $25.3K.
  • Amgen made up 0.07% of Avestar Capital's portfolio in Q2 2026, its #196 holding.
  • Avestar Capital first reported a position in Amgen in Q4 2017 and has held it in 20 quarters since.
  • Avestar Capital's Amgen position peaked at $1.66M in Q1 2025.
  • 1,530 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.